Abstract
1. Evaluate the mechanisms by which hyperglycemia and hypothyroidism occur in patients on certain targeted chemotherapy agents.2. Develop treatment recommendations for patients who develop these endocrine toxicities while on therapy.3. Establish appropriate monitoring guidelines for patient receiving certain targeted chemotherapy agents.
| Original language | American English |
|---|---|
| State | Published - Oct 22 2012 |
| Event | American College of Clinical Pharmacy (ACCP) Annual Meeting - Hollywood, FL Duration: Oct 22 2012 → … |
Conference
| Conference | American College of Clinical Pharmacy (ACCP) Annual Meeting |
|---|---|
| Period | 10/22/12 → … |
Keywords
- chemotherapy agents
- thyroid dysfunction
Disciplines
- Oncology
- Pharmacy and Pharmaceutical Sciences